Dermatology

The Digital Medicine Society (DiME) is a global nonprofit dedicated to advancing the ethical, effective, equitable, and safe use of digital medicine to redefine health care and improve lives. DiME recently released a new set of resources, available at www.dimesociety.org/access-resources/, to advance the use of digitally measured nocturnal scratch as a meaningful endpoint for atopic dermatitis. These tools, along with DiMe’s previous work to support digital clinical measures, lay the groundwork for future use of the measure in clinical research, technology development, and reimbursement decisions—thereby furthering dermatology research and improving the lives of AD patients and caregivers. Jennifer Goldsack, DiME CEO, and Lucy Cesnakova, a program lead at DiMe, discuss their work and its impact on the field. Listen now.

Physician assistants (PAs) are licensed to practice medicine to provide many of the same services as a physician. And they may even train in dermatology. But what do we need to take into consideration when bringing a PA into a dermatology practice? Joining Dr. Michael Greenberg to discuss the ethics of this all-too-common situation is Dr. John Weiss, President and Co-Managing Partner at Georgia Dermatology Partners.

Alopecia areata affects more than 300,000 people in the United States each year, causing hair loss to the scalp, eyebrows, and eyelashes. But recent studies have shown that the Janus kinase inhibitor drug baricitinib can help significantly regrow hair for patients. To find out more about what this first-ever FDA approval of a systemic treatment could mean for patients with alopecia areata, Dr. Matthew Keller speaks with Dr. Natasha Mesinkovska, Associate Professor of Dermatology and Vice Chair for Clinical Research of Dermatology at University of California Irvine.

Psoriatic disease looks and feels different for people of color, and these differences may affect their diagnosis, treatment, and—by extension—quality of life. In fact, more than 50 percent of people with psoriatic arthritis experience a 2-year delay in diagnosis and a lower quality of life compared to white patients. So how can we help close the diagnostic gap and provide better care for our patients of color with psoriatic arthritis? To find out, Dr. Michael Greenberg is joined by Dr. Lynn McKinley-Grant, Associate Professor of Dermatology at Howard University College of Medicine.

As monkeypox continues to spread across non-endemic countries, how can we detect it in our patients? And what’s being done to stop the spread? Guest and fellow ReachMD Host Dr. Randy Young, a pulmonary disease and critical care medicine physician, joins Dr. John Russell to discuss what physicians should be looking for and how this virus has impacted public health.

With the recent rise of monkeypox cases around the world, dermatologists will be some of the first to evaluate and diagnose patients with the disease. So to help those on the frontlines, Dr. Esther Freeman, Director of Global Health Dermatology at Massachusetts General Hospital and Dr. Steven Chen, Assistant Professor of Dermatology at Harvard Medical School, share what dermatologists need to know about monkeypox.

How might genomics help us provide better care for our patients? Joining Dr. Michael Greenberg to share how he’s utilizing genomics in practice is Dr. Brook Brouha, a dermatologist and dermatopathologist at West Dermatology in San Diego, California.

Are you looking to increase business at your dermatology practice? One simple solution is practicing goodness—in other words, being good and kind to your patients and their families. Joining Dr. Matthew Keller to explain why goodness is the best practice builder is fellow ReachMD Host Dr. Michael Greenberg.

The prevalence of social media has grown significantly over the past few decades, and within the field of medicine, we’ve seen a rise in dermatologists using these platforms to grow their professional network, improve patient care, and provide essential education. But what ethical challenges arise from a widespread social media presence, and how can we navigate those challenges? To find out, Dr. Michael Greenberg speaks with Dr. Dustin Portela about his online presence as 208SkinDoc.

As the most common type of eczema, atopic dermatitis is a chronic, inflammatory skin disorder that affects millions of people worldwide. And although it’s a complex disease with no cure, the FDA recently approved two oral JAK-1 inhibitors for patients with mild-to-severe-symptoms. So what do we need to know about these new treatment options? Joining Dr. Matthew Keller to review the role of JAK inhibitors in atopic dermatitis is Dr. Shawn Kwatra, Associate Professor of Dermatology at Johns Hopkins University School of Medicine and Director of the Johns Hopkins Itch Center.